Invasive aspergillosis: current and future challenges in diagnosis and therapy
- PMID: 14706080
- DOI: 10.1111/j.1469-0691.2004.00809.x
Invasive aspergillosis: current and future challenges in diagnosis and therapy
Abstract
Invasive aspergillosis is an increasingly common disease. While there have been significant advances in the past decade, significant challenges remain in terms of diagnosis and therapy. Some of the recent advances are outlined and future opportunities to improve the unacceptable mortality that is currently associated with this infection are considered.
Similar articles
-
Voriconazole versus amphotericin B for invasive aspergillosis.N Engl J Med. 2002 Dec 19;347(25):2080-1; author reply 2080-1. doi: 10.1056/NEJM200212193472518. N Engl J Med. 2002. PMID: 12490695 No abstract available.
-
Amphotericin B is still the drug of choice for invasive aspergillosis.Am J Respir Crit Care Med. 2006 Jul 1;174(1):102; author reply 102-3. doi: 10.1164/ajrccm.174.1.102a. Am J Respir Crit Care Med. 2006. PMID: 16793999 No abstract available.
-
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?J Chemother. 2011 Feb;23(1):5-8. doi: 10.1179/joc.2011.23.1.5. J Chemother. 2011. PMID: 21482486 Review.
-
Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.Ann Hematol. 2002;81 Suppl 2:S52-3. Ann Hematol. 2002. PMID: 12611078 Clinical Trial. No abstract available.
-
Pharmacoeconomic assessment of therapy for invasive aspergillosis.Mycoses. 2013 May;56(3):338-49. doi: 10.1111/myc.12036. Epub 2013 Jan 13. Mycoses. 2013. PMID: 23311989 Review.
Cited by
-
Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital.J Clin Microbiol. 2005 May;43(5):2075-9. doi: 10.1128/JCM.43.5.2075-2079.2005. J Clin Microbiol. 2005. PMID: 15872225 Free PMC article.
-
Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus.Clin Vaccine Immunol. 2011 Sep;18(9):1568-76. doi: 10.1128/CVI.05163-11. Epub 2011 Jul 6. Clin Vaccine Immunol. 2011. PMID: 21734068 Free PMC article.
-
Diagnostic Performance of (1→3)-β-D-Glucan Alone and in Combination with Aspergillus PCR and Galactomannan in Serum of Pediatric Patients after Allogeneic Hematopoietic Stem Cell Transplantation.J Fungi (Basel). 2021 Mar 22;7(3):238. doi: 10.3390/jof7030238. J Fungi (Basel). 2021. PMID: 33810069 Free PMC article.
-
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.Antimicrob Agents Chemother. 2009 Jun;53(6):2382-91. doi: 10.1128/AAC.00329-09. Epub 2009 Mar 23. Antimicrob Agents Chemother. 2009. PMID: 19307368 Free PMC article.
-
Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis.Infect Immun. 2010 Mar;78(3):1269-75. doi: 10.1128/IAI.01091-09. Epub 2009 Dec 14. Infect Immun. 2010. PMID: 20008537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous